Furthermore, HIF-1α overexpression has been demonstrated to promote HCC cell resistance to each of these drugs (Liang et al., 2013; Wu et al., 2016; Schoning et al., 2017). This evidence concerns the gene HIF1A and hepatocellular carcinoma.